NDC codes

FDA NDC Directory
Product NDC (as listed)0832-1560Labeler and product segments. Claims need a package NDC.
Product NDC at billing width00832-1560Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
0832-1560-110083215601100832156011100 TABLET in 1 BOTTLE (0832-1560-11)Marketed from Jan 13, 2020

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Haloperidol
Generic name (nonproprietary)
haloperidol
Active ingredients
Haloperidol — 20 mg/1
Dosage form
Tablet
Route
Oral
Labeler
Upsher-Smith Laboratories, LLCNDC labeler code 0832
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 211061
Marketing start
Listing expires
Identifiers
Product ID 0832-1560_ca5f7ae2-4c1e-488e-8d6f-32c3a5bfe3fbSPL ID ca5f7ae2-4c1e-488e-8d6f-32c3a5bfe3fbSPL set ID afb3ac3e-7459-42d3-b5ca-e0d6d27ced73RxCUI 197754, 310670, 310671, 310672, 314034, 314035UNII J6292F8L3D
Pharmacologic class
Typical Antipsychotic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400832156011 followed by a unit qualifier and the quantity

Package 00832-1560-11. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Haloperidol is indicated for use in the management of manifestations of psychotic disorders. Haloperidol is indicated for the control of tics and vocal utterances of Tourette's Disorder in children and adults. Haloperidol is effective for the treatment of severe behavior problems in children of combative, explosive hyperexcitability (which cannot be accounted for by immediate provocation). Haloperidol is also effective in the short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the following symptoms: impulsivity, difficulty sustaining attention, aggressivity, mood lability, and p…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0832-1560

What is NDC 0832-1560?
0832-1560 is the product NDC for Haloperidol, Haloperidol 20 mg/1 tablet, listed with the FDA by Upsher-Smith Laboratories, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Haloperidol.
What is the active ingredient?
Haloperidol.
Who is the labeler?
Upsher-Smith Laboratories, LLC, NDC labeler code 0832. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Haloperidol?
170 other product NDCs are listed under this name. See all Haloperidol NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Haloperidol NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
HaloperidolHaloperidol .5 mg/1TabletOralAjanta Pharma USA Inc.27241-26427241-0264-01
HaloperidolHaloperidol 1 mg/1TabletOralAjanta Pharma USA Inc.27241-26527241-0265-01
HaloperidolHaloperidol 2 mg/1TabletOralAjanta Pharma USA Inc.27241-26627241-0266-01
HaloperidolHaloperidol 5 mg/1TabletOralAjanta Pharma USA Inc.27241-26727241-0267-01
HaloperidolHaloperidol 10 mg/1TabletOralAjanta Pharma USA Inc.27241-26827241-0268-01
HaloperidolHaloperidol 20 mg/1TabletOralAjanta Pharma USA Inc.27241-26927241-0269-01
HaloperidolHaloperidol 10 mg/1TabletOralREMEDYREPACK INC.70518-472570518-4725-00
HaloperidolHaloperidol 5 mg/1TabletOralCoupler LLC67046-032967046-0329-03
HaloperidolHaloperidol 5 mg/1TabletOralUnit Dose Solutions, Inc.87441-03787441-0037-01
HaloperidolHaloperidol .5 mg/1TabletOralSafecor Health, LLC48433-15148433-0151-20

All 171 Haloperidol NDCs

Other NDCs under ANDA 211061

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211061
ProductStrengthForm · routeLabelerProduct NDC
HaloperidolHaloperidol .5 mg/1TabletOralUpsher-Smith Laboratories, LLC0832-1510
HaloperidolHaloperidol 1 mg/1TabletOralUpsher-Smith Laboratories, LLC0832-1520
HaloperidolHaloperidol 2 mg/1TabletOralUpsher-Smith Laboratories, LLC0832-1530
HaloperidolHaloperidol 5 mg/1TabletOralUpsher-Smith Laboratories, LLC0832-1540
HaloperidolHaloperidol 10 mg/1TabletOralUpsher-Smith Laboratories, LLC0832-1550

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in